Consortium Investigators

Consortium key investigators and members at a glance.

The goal of the PCTC is to translate advances in progenitor cell biology towards application to heart, lung, and blood diseases. The initiative will focus on the use of progenitor cell-based disease models to understand disease mechanisms and to develop novel therapies, and the application of progenitor cell-based therapies for the treatment of heart, lung, and blood diseases.

For information on specific research goals, check out the research groups.